Stem Cells · 2012 · 753 citations · 37 references
Life SciencesBiomedical SciencesBiotechnologyRegenerative MedicineStem Cell BiologyStem Cell BiotechnologyPluripotent Stem CellsStem Cell BioengineeringStem Cell DifferentiationCord Blood CellsHuman Induced Pluripotent Stem Cell ModelsInduced Pluripotent Stem CellsIntegration-free ReprogrammingPlasmid Dna VectorsPlasmid VectorsPluripotency InductionReprogramming Of Somatic Cells
Induced pluripotent stem cells (iPSCs) enable the use of patient‑specific somatic cells for disease modeling and drug discovery. The study aims to develop a protocol that generates iPSCs from easily accessible blood cells, specifically CD34+ cord blood and peripheral blood from healthy donors, using plasmid vectors. The protocol employs plasmids encoding OCT3/4, SOX2, KLF4, L‑MYC, LIN28, shRNA for TP53, and an additional EBNA1 plasmid to enhance episomal amplification, thereby improving induction efficiency, especially from α.
The generation of induced pluripotent stem cells (iPSCs) provides the opportunity to use patient-specific somatic cells, which are a valuable source for disease modeling and drug discovery. To promote research involving these cells, it is important to make iPSCs from easily accessible and less invasive tissues, like blood. We have recently reported the efficient generation of human iPSCs from adult fibroblasts using a combination of plasmids encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, and shRNA for TP53. We herein report a modified protocol enabling efficient iPSC induction from CD34+ cord blood cells and from peripheral blood isolated from healthy donors using these plasmid vectors. The original plasmid mixture could induce iPSCs; however, the efficiency was low. The addition of EBNA1, an essential factor for episomal amplification of the vectors, by an extra plasmid greatly increased the efficiency of iPSC induction, especially when the induction was performed from αβT cells. This improvement enabled the establishment of blood-derived iPSCs from seven healthy donors ranging in age from their 20s to their 60s. This induction method will be useful for the derivation of patient-specific integration-free iPSCs and would also be applicable to the generation of clinical-grade iPSCs in the future.
37
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki et al. · Cell · 2007 · 20.2K citations
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo, Eric Banks, Ryan Poplin et al. · Nature Genetics · 2011 · 12.4K citations · Full text
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Junying Yu, Maxim A. Vodyanik, Kim Smuga-Otto et al. · Science · 2007 · 10.3K citations